Valeant Pharma Rallies The Day After Ackman Touts The Issue On CNBC

Valeant Pharma Inc. VRX shares are trading higher by $3.30 at $35.95 in Tuesday's session. One day after Bill Ackman of Pershing Square explained his bullish thesis on the issue via CNBC, the issue is staging a rally. Following a higher, it retreated and found support just below Monday's close ($32.65), reaching $32,25 before staging a rebound. The ensuing rally has found resistance in a familiar area. Since putting in the low for the recent down move on April 4 at $25.27, the issue has made several attempts to clear out the major resistance at the $38 area. Four days after making the panic-induced low, it staged as sharp rally that ended at $38.18. Once again, on April 25, it is attempted to break out to the upside, but the rally stalled at $37.90. In today's session, it cleared both of those hurdles and made it to $38.50, bringing in the momentum traders looking for a move to $40 and beyond. However, the rallied has failed again and these traders are being forced to quickly exit on weakness. Roberto Pedone of Zero-Sum Trading commented on the day's trading action. "Haven't seen any monster blocks on it, but volume overall is over 47 million, which is way above the 3-month average of 26.7 million. So this is getting some serious institutional flow today. "
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: TechnicalsIntraday UpdateMoversTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!